Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

NCT02079207 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

767

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: NBP606
BIOLOGICAL: Prodiax-23

Sponsor

SK Chemicals Co., Ltd.